Covid19

FDA: COVID-19 Moderna Vaccine Dose Needs to be Adjusted for Pediatric Population

The FDA is highlighting dosing information for Moderna's COVID-19 Vaccine (2023-2024 Formulation) in children aged 6 months to 11 years, after the …

Read more at www.contagionlive.com

Show More

Related Articles

Back to top button